CID 16131452

[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1h-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl 2,2-diphenylethyl hydrogen phosphate

Structural Information

Molecular Formula
C74H87N27O37P6
SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OCC(C3=CC=CC=C3)C4=CC=CC=C4)OP(=O)(O)OCC5C(CC(O5)N6C=NC7=C6N=C(NC7=O)N)OP(=O)(O)OCC8C(CC(O8)N9C=NC1=C9N=C(NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)O
InChI
InChI=1S/C74H87N27O37P6/c1-32-18-96(74(108)95-65(32)103)49-13-37(43(129-49)21-122-139(109,110)121-19-35(33-8-4-2-5-9-33)34-10-6-3-7-11-34)134-141(113,114)125-23-45-39(15-51(131-45)99-29-84-56-62(99)88-71(77)92-67(56)105)137-143(117,118)127-25-47-41(17-53(133-47)101-31-86-58-64(101)90-73(79)94-69(58)107)138-144(119,120)126-24-46-40(16-52(132-46)100-30-85-57-63(100)89-72(78)93-68(57)106)136-142(115,116)124-22-44-38(14-50(130-44)97-27-82-54-59(75)80-26-81-60(54)97)135-140(111,112)123-20-42-36(102)12-48(128-42)98-28-83-55-61(98)87-70(76)91-66(55)104/h2-11,18,26-31,35-53,102H,12-17,19-25H2,1H3,(H,109,110)(H,111,112)(H,113,114)(H,115,116)(H,117,118)(H,119,120)(H2,75,80,81)(H,95,103,108)(H3,76,87,91,104)(H3,77,88,92,105)(H3,78,89,93,106)(H3,79,90,94,107)
InChIKey
ITPZGFZQASIEDH-UHFFFAOYSA-N
Compound name
[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl 2,2-diphenylethyl hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

2131.4182 Da
Monoisotopic Mass

-9.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 2132.4255 235.9
[M+Na]+ 2154.4074 246.3
[M-H]- 2130.4109 235.4
[M+NH4]+ 2149.4520 239.3
[M+K]+ 2170.3814 243.3
[M+H-H2O]+ 2114.4155 234.2
[M+HCOO]- 2176.4164 240.3
[M+CH3COO]- 2190.4321 242.2
[M+Na-2H]- 2152.3929 243.5
[M]+ 2131.4177 244.2
[M]- 2131.4187 244.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.